HF
VBIO

HRT Financial’s Valion Bio VBIO Stock Holding History

HRT Financial’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Sell
458
-1,239
-73% -$27K ﹤0.01% 4028
2026
Q1 		$37K Buy
+1,697
New +$43.4K ﹤0.01% 3498
2025
Q1 		– Sell
-138
Closed -$19K – 3381
2024
Q4 		$19K Buy
+138
New +$16K ﹤0.01% 2214
2023
Q3 		– Sell
-1
Closed -$2K – 3094
2023
Q2 		$2K Hold
1
– – ﹤0.01% 2289
2023
Q1 		$4K Buy
+1
New +$17.5K ﹤0.01% 2307

Other funds holding VBIO

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

HRT Financial's VBIO Position: Q2 2026 in Review

HRT Financial reduced its Valion Bio (VBIO) stake by 73% in Q2 2026, selling an estimated $27K and leaving 458 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4028.

HRT Financial first reported a position in VBIO in Q1 2023 and has held it in 5 quarters since. The position peaked at $37K in Q1 2026. 11 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

  • HRT Financial held 458 shares of Valion Bio worth $5K as of Q2 2026.
  • HRT Financial sold 1,239 Valion Bio shares in Q2 2026, an estimated $27K.
  • Valion Bio made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #4028 holding.
  • HRT Financial first reported a position in Valion Bio in Q1 2023 and has held it in 5 quarters since.
  • HRT Financial's Valion Bio position peaked at $37K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.